170 related articles for article (PubMed ID: 31058279)
1. Tissue Transglutaminase Appears in Monocytes and Macrophages but Not in Lymphocytes in White Matter Multiple Sclerosis Lesions.
Chrobok NL; Bol JGJM; Wilhelmus MMM; Drukarch B; van Dam AM
J Neuropathol Exp Neurol; 2019 Jun; 78(6):492-500. PubMed ID: 31058279
[TBL] [Abstract][Full Text] [Related]
2. Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter.
Espitia Pinzon N; Stroo E; 't Hart BA; Bol JG; Drukarch B; Bauer J; van Dam AM
PLoS One; 2014; 9(6):e100574. PubMed ID: 24959868
[TBL] [Abstract][Full Text] [Related]
3. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
[TBL] [Abstract][Full Text] [Related]
4. Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells?
Sestito C; Brevé JJP; van Eggermond MCJA; Killestein J; Teunissen CE; van Rossum J; Wilhelmus MMM; Drukarch B; van den Elsen PJ; van Dam AM
J Neuroinflammation; 2017 Dec; 14(1):257. PubMed ID: 29268771
[TBL] [Abstract][Full Text] [Related]
5. Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?
Chrobok NL; Sestito C; Wilhelmus MM; Drukarch B; van Dam AM
Amino Acids; 2017 Mar; 49(3):441-452. PubMed ID: 27659795
[TBL] [Abstract][Full Text] [Related]
6. Tissue Transglutaminase contributes to myelin phagocytosis in interleukin-4-treated human monocyte-derived macrophages.
Sestito C; Brevé JJP; Bol JGJM; Wilhelmus MMM; Drukarch B; van Dam AM
Cytokine; 2020 Apr; 128():155024. PubMed ID: 32032932
[TBL] [Abstract][Full Text] [Related]
7. Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration?
van Strien ME; Drukarch B; Bol JG; van der Valk P; van Horssen J; Gerritsen WH; Breve JJ; van Dam AM
Brain Pathol; 2011 Jan; 21(1):44-54. PubMed ID: 20731658
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Transglutaminase 2 activity inhibitors in monocytes in vitro and their effect in a mouse model for multiple sclerosis.
Chrobok NL; Bol JGJM; Jongenelen CA; Brevé JJP; El Alaoui S; Wilhelmus MMM; Drukarch B; van Dam AM
PLoS One; 2018; 13(4):e0196433. PubMed ID: 29689097
[TBL] [Abstract][Full Text] [Related]
9. Monocyte behaviour and tissue transglutaminase expression during experimental autoimmune encephalomyelitis in transgenic CX3CR1
Chrobok NL; Jaouen A; Fenrich KK; Bol JG; Wilhelmus MM; Drukarch B; Debarbieux F; van Dam AM
Amino Acids; 2017 Mar; 49(3):643-658. PubMed ID: 27826792
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size.
Boisvert WA; Rose DM; Boullier A; Quehenberger O; Sydlaske A; Johnson KA; Curtiss LK; Terkeltaub R
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):563-9. PubMed ID: 16410462
[TBL] [Abstract][Full Text] [Related]
11. Transglutaminase 2 is expressed and active on the surface of human monocyte-derived dendritic cells and macrophages.
Hodrea J; Demény MA; Majai G; Sarang Z; Korponay-Szabó IR; Fésüs L
Immunol Lett; 2010 May; 130(1-2):74-81. PubMed ID: 20005901
[TBL] [Abstract][Full Text] [Related]
12. Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures.
Espitia Pinzón N; Brevé JJP; Bol JGJM; Drukarch B; Baron W; van Dam AM
J Neuroinflammation; 2017 Dec; 14(1):260. PubMed ID: 29282083
[TBL] [Abstract][Full Text] [Related]
13. Imaging of the ex vivo transglutaminase activity in liver macrophages of sepsis mice.
Su T; Qin XY; Furutani Y; Yu W; Kojima S
Anal Biochem; 2020 May; 597():113654. PubMed ID: 32142762
[TBL] [Abstract][Full Text] [Related]
14. Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment.
van Wageningen TA; Vlaar E; Kooij G; Jongenelen CAM; Geurts JJG; van Dam AM
Acta Neuropathol Commun; 2019 Dec; 7(1):206. PubMed ID: 31829283
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminase 2 limits murine peritoneal acute gout-like inflammation by regulating macrophage clearance of apoptotic neutrophils.
Rose DM; Sydlaske AD; Agha-Babakhani A; Johnson K; Terkeltaub R
Arthritis Rheum; 2006 Oct; 54(10):3363-71. PubMed ID: 17009310
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase 2 is involved in homocysteine-induced activation of human THP-1 monocytes.
Currò M; Gangemi C; Gugliandolo A; Risitano R; Ferlazzo N; Ientile R; Caccamo D
Free Radic Res; 2015 Mar; 49(3):299-308. PubMed ID: 25547897
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2 and phospholipase A₂ interactions in the inflammatory response in human Thp-1 monocytes.
Currò M; Ferlazzo N; Risitano R; Condello S; Vecchio M; Caccamo D; Ientile R
Amino Acids; 2014 Mar; 46(3):759-66. PubMed ID: 23913269
[TBL] [Abstract][Full Text] [Related]
18. Neuronal and Endothelial Transglutaminase-2 Expression during Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Pearse DD; Otero PA; Diaz A; Pan X; Ghosh M
Neuroscience; 2021 May; 461():140-154. PubMed ID: 33253822
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions.
Vos CM; van Haastert ES; de Groot CJ; van der Valk P; de Vries HE
J Neuroimmunol; 2003 May; 138(1-2):106-14. PubMed ID: 12742660
[TBL] [Abstract][Full Text] [Related]
20. Monocyte/macrophage differentiation in early multiple sclerosis lesions.
Brück W; Porada P; Poser S; Rieckmann P; Hanefeld F; Kretzschmar HA; Lassmann H
Ann Neurol; 1995 Nov; 38(5):788-96. PubMed ID: 7486871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
